IST Priority - National Contact Point meeting Brussels, 6 th May 2004

1. IST Priority - National Contact Point meetingBrussels, 6th May 2004 2nd Joint Call IST/NMP Evangelos OUZOUNISEuropean Commission – DG Information SocietyDirectorate C

2. Presentation outline • Why a joint call? • What is under the 2nd joint call? • Nanoelectronics, nanophotonics • Biosensors • Manufacturing • Conclusions – on joint call • IMS - Intelligent Manufacturing Systems

3. Why a Joint Call? • Synergies • Areas of relevance to both, IST & NMP • Bundle resources for inter-disciplinary R&D, avoid gaps, overlaps, duplications of effort • Joint Call involves several IST and NMP units in common domains • Need to fulfil int’l commitments (e.g. launch IMS projects) • In particular in the 2nd Joint Call • Three areas of complementarity between IST & NMP (nano-, biosensors, manufacturing/IMS) • Joint Call areas identified in IST and NMP WP2004 • A tradition ... • Continuation of good collaboration between IST & GROWTH programmes of FP5 (IMS) • Both IST and NMP value the importance of ICTs in developing further and maintaining a “knowledge-driven industrial base” for Europe

4. Joint Call - Area 3 Materials, equipment & processes for productionof nano-photonics & nano-electronics devices R&D focus: • Nano-electronic and nano-photonic/optical materials (e.g. compound semiconductors, functional polymer and glass materials) and related fabrication processes • Integrated non-conventional nano-MOS logic and memory devices, photonics/nano-electronics integration technologies for functional devices, and related production technologies • Materials, processes and equipment for very advanced nano-structuring and nano-patterning technologies required for the high volume production of nano-electronic and nano-photonic integrated circuits Funding: 60 M€ Instruments: IP, STREP (radical innovation), SSA To master nanoelectronics & nanophotonicsfor low-cost mass production Objective

5. Joint Call - Area 2 Bio-sensors for Diagnosis & Healthcare R&D focus: • Development of technological platforms, taking into account all aspects of the life cycle of biomedical sensors and health monitoring systems • Radical improvement of sensitivity, accuracy, precision, stability, selectivity, reproducibility, reliability, cost and where necessary sterilisation and bio-compatibility • Integration activities aiming at increasing molecular (MR) and cellular recognition (CR) capabilities • Activities addressing health issues in a holistic manner using and/or including the development of bio-sensor-based integrated systems Funding: 60 M€ Instruments: IP, STREP (radical innovation), SSA Integration of bio-sensors & smart/hybrid materialsfor innovative bio-medical sensing & intelligent diagnosis Objective

6. Joint Call - Area 1 Integrating Technologies for Fast & Flexible Manufacturing R&D focus: • Advanced control and networking of embedded systems for dynamic reconfiguration of complex manufacturing processes • Multidisciplinary and dynamic work environments facilitating multi-stakeholder involvement and life cycle management of manufacturing systems, products and services • Innovative approaches to customisation fulfilment, logistics and maintenance via mobile miniature and wireless devices or smart tags Funding: 60 M€ Instruments: IP, STREP (radical innovation, international cooperation, IMS), SSA To support European leadership inengineering & manufacturing Objective int’l R&Dcollaboration (IMS) IST Strategic Objective:“Products & Services Engineering 2010”

7. Joint Call: other details • Call identifier: FP6-2004-IST-NMP-2 • Publication: beginning of June 2004 • Deadline: 14 October 2004 at 17h00 • Submission in a single stage (+ hearings for IP) • See all relevant call documents, when published, in: http://fp6.cordis.lu/fp6/calls_open.cfm

8. Joint Call: Conclusions • The rationale for the Joint Call is manifold: • an opportunity to create synergies within FP6 • at the initiative of IST and NMP priorities in FP6 (WP2004) • a need to launch international activities • New focus areas (2 and 3): • nano-electronics & nano-photonics • bio-sensors for diagnosis and healthcare • Manufacturing area: • need to put emphasis on IMS-relevant projects (mainly STREPs – or IP) • need to support ICT competence in manufacturing

9. Area 3: Nano-electronics and nano-photonicsGeorg.Kelm@cec.eu.int Area 2: BiosensorsAndreas.Lymberis@cec.eu.intor Jean-Marie.Auger@cec.eu.int Area 1: Manufacturing Paolo.Garello@cec.eu.int Area 3: Nano-electronics, and nano-photonicsHeico.Frima@cec.eu.int Area 2: BiosensorsUta.Faure@cec.eu.int Area 1: ManufacturingAndrea.Gentili@cec.eu.int Contact points for IST-NMP joint call - - by area

10. IMS: Intelligent Manufacturing Systems

11. IMS in a nutshell • R&D collaboration framework between developed countries • EU, US, Japan, Canada, Australia, Korea, Norway, Switzerland • industry-led • solid Intellectual Property Rights (IPR) provisions • R&D portfolio • ~300 M€ worldwide total R&D investment so far • funded EU participation in ~40 int’l R&D projects • ~100 M€ funding under FP4 and FP5 - shared between IST & GROWTH • Participants’ profile • 200+ large industrial companies • 120+ SMEs (=18 %) • 220+ academic/research institutes • Regional participation • EU (43%), Japan (21%), US (13%), other world regions (23%)

12. IMS: additional background infowww.ims.org • History: • Original idea: Japan (1989) • Feasibility study: 1992 (6 test cases, EU involvement under Esprit) • Full 10-year programme: launched April 1995 • New IMS Agreement under negotiation (likely launch May 2005) • Initial participants: • Australia, Canada, Japan, Switzerland, US • Additional participants: • EU and Norway (1997) • Korea (2001) • IMS Forum 2004: • 17-19 May 2004 in Como